Down Syndrome Trial May Hold Key To Learning

An ingredient used for decades in cough syrup, and to treat a variety of conditions, could hold the key to improving memory, language, and learning in people with Down syndrome. In the first trial of its kind targeting cognitive impairment in people with Down syndrome, researchers at Monash University are currently investigating the effectiveness of the ingredient, known as BTD-001, and its potential to significantly improve the quality of life of people with Down syndrome - the most common genetic form of intellectual disability affecting 6 million people worldwide...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news